Clinical Trials Browser

INDUSTRY × Has results × Adalimumab × Clear all

NCT05073315 2024-02-09

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Phase 3 Completed

425 enrolled 22 charts

Plaque Psoriasis

NCT02092467 2021-08-17

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Phase 4 Completed

4,372 enrolled 22 charts

Arthritis, Rheumatoid

NCT02163759 2021-07-23

HIBISCUS I

Phase 3 Completed

358 enrolled 42 charts

Colitis, Ulcerative

NCT02171429 2021-07-23

HIBISCUS II

Phase 3 Completed

358 enrolled 38 charts

Colitis, Ulcerative

NCT02499783 2019-01-04

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Phase 3 Completed

205 enrolled 39 charts

Crohn Disease

NCT02196701 2018-03-19

CLEAR

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

NCT01635764 2018-01-24

PIONEER (OLE)

Phase 3 Completed

508 enrolled 9 charts

Abscess, Acne Vulgaris, Hidradenitis Suppurativa

NCT00595413 2016-02-17

AUGUST II

Phase 2 Completed

311 enrolled 13 charts

Arthritis, Rheumatoid

NCT01283971 2014-02-10

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Phase 4 Terminated

96 enrolled 27 charts

Arthritis, Rheumatoid

NCT00420927 2012-04-18

OPTIMA

Phase 4 Completed

1,032 enrolled 25 charts

Arthritis, Rheumatoid

NCT01078571 2011-10-28

DALI

705 enrolled 15 charts

Arthritis, Rheumatoid

NCT00085644 2011-04-21

ATLAS

Phase 3 Completed

315 enrolled 45 charts

Spondylitis, Ankylosing